AI Science Tracker

COSTAR predicts drug activity tested in glioblastoma samples

ETH Zurich; University Hospital Zurich; University of Zurich · 20 Sep 2024 · medicine

Discovery

COSTAR predicts drug activity tested in glioblastoma samples

A learned drug-target connectivity signature selected 23 predicted hits and 25 negatives for testing in four glioblastoma patient samples. Ex-vivo measurements agreed with predictions at a reported mean ROC AUC of 0.94. The small validation establishes a bounded drug-activity prediction result, not clinical response. Vortioxetine was found by the initial experimental screen and is not attributed to COSTAR nomination.

Technology: COSTAR logistic LASSO drug-target model

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Newly selected compounds were tested ex vivo across four patient samples.
  • Still unknown: Patient benefit, generalization and clinical safety remain unestablished.
  • AI role: COSTAR logistic LASSO drug-target model supported the stated study; experimental and interpretive work remained with researchers.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11564103/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary full-text model Methods and selected experimental Results, publication metadata and affiliations; supplements not reviewed..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.